Changes in use of disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States during 1983-2009.

@article{Kim2013ChangesIU,
  title={Changes in use of disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States during 1983-2009.},
  author={Seoyoung C Kim and Ed H Yelin and Chris Tonner and Daniel H. Solomon},
  journal={Arthritis care & research},
  year={2013},
  volume={65 9},
  pages={1529-33}
}
OBJECTIVE Use of nonbiologic disease-modifying antirheumatic drugs (DMARDs) and/or biologic DMARDs is generally recommended to improve the prognosis of patients with rheumatoid arthritis (RA). The objective of this study was to describe the changing trends in DMARD use for RA over the past 2 decades. METHODS We analyzed data from an open longitudinal cohort of RA patients recruited from rheumatologists' practices in northern California. We examined baseline demographic and clinical… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Methotrexate enhances 3T3-L1 adipocytes hypertrophy

Cell Biology and Toxicology • 2013
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…